To OTC Journal Members:
 

Comments in the BLOG

In light of the recent big moves in some of the stocks the OTC Journal is covering, I have updated most of the price targets, and more importantly, the SSLs (suggested stop losses). We are in a hot market right now, but don't forget last summer when the microcap world got clobbered. It can turn that way in a hurry. As these stocks move up, it is important to raise the SSLs as well in the event a stock trades against you. Fortunately, we are now at a point when most of the SSLs are above the entry levels.

Have a look at the left hand menu bar on the home page at www.otcjournal.com for the latest Targets and Stops, and check back for new BLOGS frequently.

The BLOG is your opportunity to ask questions and offer comments. I will make an effort to answer every legitimate question. If I don't know the answer, I will contact the management and get the answer. Alternatively, if you have questions you don't want publicly displayed, you can always email me directly at editor@otcjournal.com.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG scrolls down from the upper right hand corner. The most current journal entries appear on the right hand side of you screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels in volatile markets.
 

eFoodSafety (OTC BB: EFSF) Defying Gravity

EFSF seems to be capable of defying gravity. The company hasn't said much the last couple of days, yet the stock continues powering to new multi month highs on very strong volume. On Monday, the stock traded to a high of $.34 on 2.7 million shares of volume (70% higher than the entry level 2 weeks ago), and closed at $.32. If you took some or all of your profits at or above $.30, you have to be scratching your head wondering if you made a mistake honoring my target price.

Over the weekend I revised my target price to $.40 and my SSL to $.23. This upgrade is based entirely on how well this stock is trading. Looking back at its history, I wonder if the stock is going to rocket up the charts like it did 10 months ago in March of 2006. It was a great opportunity to sell the stock at a huge profit, but you only had a day or two to get out near the top. If the stock has some sort of huge explosion to the upside, you will have to be watching and be ready to lock in your profits.

Today, just before the market opened, EFSF issued another press release which could send this stock charging up to my next target level of $.40. The company announced it is ready to start distributing its natural cholesterol fighting product Cinnechol™ within the next 60 days.

The product's formula and packaging are now complete and ready for market. EFSF intends to use its established channels of distribution following the template employed to market Cinnergen.

So, where to from here? Today's news could put another charge into this stock, and the stock definitely has momentum. It strikes me that in light of this great chart, we could be seeing a short squeeze forming in this stock.

Here's the big question- if this is a short squeeze, and you sold the stock and took your profits at $.30 plus, do you buy back in now? Hopefully, you haven't sold it all. If you have, you should definitely buy some back. It is defying gravity, but the way this one is trading, it could continue to defy gravity for some time to come. Here's one idea- as the stock goes up one penny, raise your SSL by one penny and limit your downside in the event of a correction.

Here is the complete text of today's press release for your review:
 

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. MarketByte LLC has been paid a fee of $30,000 cash and 1 million newly issued restricted shares by eFoodSafety for coverage of the company.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund.  Longview ocassoinally refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies. 

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.